Break free from Quality Roadblocks

Join our experts from Lachman, Regenxbio, PPD and Etena Therapeutics as they discuss key consideration of successful CGT manufacturing and quality strategies. 

Key discussions will include:  

  • Developing a successful regulatory strategy in the evolving CGT field
  • Achieving CGT quality and compliance through effective quality systems implementation
  • Navigating increasing CGT manufacturing demand and capacity and scalability challenge
  • Avoiding quality and compliance issues to ensure patient access
Register now

                   Meet the speakers

Sarah Thomas

Senior Vice President of Quality, REGENXBIO

Keith A. Lamb, Ph.D.

Executive Director, Lachman Consultant Services, Inc.

Susan McClatchey

Vice President, Quality, Eterna Therapeutics

Richard Dennett

Senior Director CMC & Regulatory Strategy, PPD | Thermo Fisher Scientific

Shardha Millington

Consultant, Citeline Moderator

Gain insight into successful strategies in overcoming obstacles in CGT manufacturing and quality

Register now to secure your spot!

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio
By completing this form you agree Lachman Consultant Services, Inc. and Pharma Intelligence may contact you directly about industry news, products, services and events that may be of interest to you subject to their privacy policy and Pharma Intelligence UK Ltd’s privacy policy.